Lallas, K., Chatziioannou, E., Durak, D., Frey, G., Serna-Higuita, L. M., Rasch, M., . . . Amaral, T. Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLallas, Konstantinos, et al. Discontinuation of Immune Checkpoint Inhibitors for Reasons Other than Disease Progression and the Impact on Relapse and Survival of Advanced Melanoma Patients. A Systematic Review and Meta-analysis. Frontiers Media S.A.
MLA (9th ed.) CitationLallas, Konstantinos, et al. Discontinuation of Immune Checkpoint Inhibitors for Reasons Other than Disease Progression and the Impact on Relapse and Survival of Advanced Melanoma Patients. A Systematic Review and Meta-analysis. Frontiers Media S.A.